S2-Leitlinie zur Diagnostik und Therapie der infektiösen Endokarditis

Trappe, HJ (2003) Leitlinien der Deutschen Gesellschaft für Kardiologie—Herz- und Kreislaufforschung. Z Kardiol 92:689–693

Delbecq AL, Van de Ven AH, Gustafson DH (1975) Group techniques for program planning. Glenview, IL, Scott, Foresman and Company

Evangelista A, Gonzalez-Alujas MT (2004) Echocardiography in infective endocarditis. Heart 90:614–617

Erbel R, Rohmann S, Drexler M, Mohr-Kahaly S, Gerharz CD, Iversen S, Oelert H, Meyer J (1988) Improved diagnostic value of echocardiography in patients with infective endocarditis by transoesophageal approach. A prospective study. Eur Heart J 9:43–53

Daniel WG, Mugge A, Martin RP, Lindert O, Hausmann D, Nonnast-Daniel B, Laas J, Lichtlen PR (1991) Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med 324:795–800

Piper C, Hetzer R, Korfer R, Bergemann R, Horstkotte D (2002) The importance of secondary mitral valve involvement in primary aortic valve endocarditis; the mitral kissing vegetation. Eur Heart J 23:79–86

Di Salvo G, Habib G, Pergola V, Avierinos JF, Philip E, Casalta JP, Vailloud JM, Derumeaux G, Gouvernet J, Ambrosi P, Lambert M, Ferracci A, Raoult D, Luccioni R (2001) Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol 37:1069–1076

Rohmann S, Erbel R, Darius H, Gorge G, Makowski T, Zotz R, Mohr-Kahaly S, Nixdorff U, Drexler M, Meyer J (1991) Prediction of rapid versus prolonged healing of infective endocarditis by monitoring vegetation size. J Am Soc Echocardiogr 4:465–474

Mügge A, Daniel WG, Frank G, Lichtlen PR (1989) Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. J Am Coll Cardiol 14:631–638

Weinstein MP (1996) Current blood culture methods and systems: clinical concepts, technology, and interpretation of results. Clin Infect Dis 23:40–46

Morris AJ, Drinkovic D, Pottumarthy S, Strickett MG, MacCulloch D, Lambie N, Kerr AR (2003) Gram Stain, Culture, and Histopathological Examination Findings for Heart Valves Removed because of Infective Endocarditis Clin Infect Dis 36:697–704

Chuard C, Antley CM, Reller LB (1998) Clinical utility of cardiac valve Gram stain and culture in patients undergoing native valve replacement. Arch Pathol Lab Med 122:412–415

Brouqui P, Raoult D (2001) Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev 14:177–207

Goldenberger D, Kunzli A, Vogt P, Zbinden R, Altwegg M (1997) Molecular diagnosis of bacterial endocarditis by broad-range PCR amplification and direct sequencing. J Clin Microbiol 35:2733–2739

Lisby G, Gutschik E, Durack DT (2002) Molecular methods for diagnosis of infective endocarditis. Infect Dis Clin North Am 16:393–412

Bosshard PP, Kronenberg A, Zbinden R, Ruef C, Bottger EC, Altwegg M (2003) Etiologic diagnosis of infective endocarditis by broad-range polymerase chain reaction: a 3-year experience. Clin Infect Dis 37:167–172

Millar B, Moore J, Mallon P, Xu J, Crowe M, Mcclurg R, Raoult D, Earle J, Hone R, Murphy P (2001) Molecular diagnosis of infective endocarditis—a new Duke’s criterion. Scand J Infect Dis 33:673–680

Murdoch DR (2003) Diagnosis of Legionella infection. Clin Infect Dis 36:64–69

Naber CK, Erbel R (2003) Diagnosis of culture negative endocarditis: novel strategies to prove the suspect guilty. Heart 89:241–243

Habib G, Derumeaux G, Avierinos JF, Casalta JP, Jamal F, Volot F, Garcia M, Lefevre J, Biou F, Maximovitch-Rodaminoff A, Fournier PE, Ambrosi P, Velut JG, Cribier A, Harle JR, Weiller PJ, Raoult D, Luccioni R (1999) Value and limitations of the Duke criteria for the diagnosis of infective endocarditis. J Am Coll Cardiol 33:2023–2029

Kupferwasser LI, Darius H, Muller AM, Martin C, Mohr-Kahaly S, Erbel R, Meyer J (2001) Diagnosis of culture-negative endocarditis: the role of the Duke criteria and the impact of transesophageal echocardiography. Am Heart J 142:146–152

Rognon R, Kehtari R, Francioli P (1999) Individual value of each of the Duke criteria for the diagnosis of infective endocarditis. Clin Microbiol Infect 5:396–403

Uh Y, Shin DH, Jang IH, Hwang GY, Lee MK, Yoon KJ, Kim HY (2004) Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea. J Antimicrob Chemother 53:1095–1097

Stein DS, Nelson KE (1987) Endocarditis due to nutritionally deficient streptococci: therapeutic dilemma. Rev Infect Dis 9:908–916

Karchmer AW, Moellering RC Jr, Maki DG, Swartz MN (1979) Singleantibiotic therapy for streptococcal endocarditis. JAMA 241:1801–1806

Francioli P, Etienne J, Hoigne R, Thys JP, Gerber A (1992) Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility. JAMA 267:264–267

Wilson WR, Thompson RL, Wilkowske CJ, Washington JA, Giuliani ER, Geraci JE (1981) Short-term therapy for streptococcal infective endocarditis. Combined intramuscular administration of penicillin and streptomycin. JAMA 245:360–363

Perillo JE, Porst, MH et al (1979) Endocarditis due to resistent viridans streptoccoci during dental penicillin prophylaxis NEJM 300:296–300

Wilson AP, Gaya H (1996) Treatment of endocarditis with teicoplanin: a retrospective analysis of 104 cases. J Antim Chemoth 38:507–521

Presterl E, Graninger W, Georgopoulos A (1992) The efficacy of teicoplanin in the treatment of endocarditis caused by gram-positive bacteria J Antimicrobial Chemother 31:755–766

Fruden TR, Munriff SS (1993) Emergence of vancomycin-resistant endocarditis in New York City. Lancet 342:76

Babcock HM, Ritchie DJ, Christiansen E, Starlin R, Little R, Stanley S (2001) Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid. Clin Infect Dis 32:1373–1375

Thompson RL, Lavin B, Talbot GH (2003) Endocarditis due to vancomycin-resistant Enterococcus faecium in an immunocompromised patient: cure by administering combination therapy with quinupristin/dalfopristin and high-dose ampicillin. South Med J 96:818–820

Patterson JE, Sweeney AH, Simms M, Carley N, Mangi R, Sabetta J, Lyons RW (1995) An analysis of 110 serious enterococcal infections. Epidemiology, antibiotic susceptibility, and outcome. Medicine (Baltimore) 74:191–200

Wilson WR, Wilkowski CJ et al (1984) Treatment of streptomycin susceptible and streptomycin resistant enterococcal endocarditis. Ann Int Med 100:816–823

Schmit JL (1992) Efficiency of teicomplanin for enterococcal infection: 63 cases and review. Clin Infect Dis 15:302–306

Westenfelder GO, Peterson PJ et al (1973) Vancomycin-streptomycin synergism in enterococcal endocarditis JAMA 223:37–40

Witte W, Braulke C, Cuny C, Heuck D, Kresken M (2001) Changing pattern of antibiotic resistance in methicillin-resistant Staphylococcus aureus from German hospitals. Infect Control Hosp Epidemiol 22:683–686

Small PM, Chambers HF (1990). Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother 34:1227–1231

Karchmer AW, Archer GL, Dismukes WE (1983) Rifampin treatment of prosthetic valve endocarditis due to Staphylococcus epidermidis. Rev Infect Dis 5(Suppl 3):S543–S548

Archer GL, Johnston JL, Vazquez GJ, Haywood HB III (1983) Efficacy of antibiotic combinations including rifampin against methicillin-resistant Staphylococcus epidermidis: in vitro and in vivo studies. Rev Infect Dis 5(Suppl 3):S538–S542

Lucet JC, Herrmann M, Rohner P, Auckenthaler R, Waldvogel FA, Lew DP (1990) Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 34:2312–2317

Rouse MS, Wilcox RM, Henry NK, Steckelberg JM, Wilson WR (1990) Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis. Antimicrob Agents Chemother 34:273–276

Karchmer AW, Archer GL, Dismukes WE (1983) Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiological and clinical observations as guides to therapy. Ann Int Med 98:447–453

Vandenesch F, Etienne J, Reverdy ME, Eykyn SJ (1993) Endocarditis due to Staphylococcus lugdunensis: report of 11 cases and review. Clin Infect Dis 17:871–876

Wilson WR, Karchmer AW, Dajani AS, Taubert KA, Bayer A, Kaye D, Bisno AL, Ferrieri P, Shulman ST, Durack DT (1995) Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. JAMA 274:1706–1713

Fantin B, Farinotti R, Thabaut A, Carbon C (1994) Conditions for the emergence of resistance to cefpirome and ceftazidime in experimental endocarditis due to Pseudomonas aeruginosa. J Antimicrob Chemother 33:563–569

Pefanis A, Giamarellou H, Karayiannakos P, Donta I (1993) Efficacy of ceftazidime and aztreonam alone or in combination with amikacin in experimental left-sided Pseudomonas aeruginosa endocarditis. Antimicrob Agents Chemother 37:308–313

Ellis ME, Al Abdely H, Sandridge A, Greer W, Ventura W (2001) Fungal endocarditis: evidence in the world literature, 1965–1995. Clin Infect Dis 32:50–62

Donal E, Abgueguen P, Coisne D, Gouello JP, McFadden EP, Allal J, Corbi P (2001) Echocardiographic features of Candida species endocarditis: 12 cases and a review of published reports. Heart 86:179–182

Muehrcke DD, Lytle RW (1995) Surgical an long term antifungal therapy for fungal prosthetic valve endocarditis. Ann Thorac Surg 60:538–543

Duroux-Vouilloz C, Praz G, Francioli P, Peter O (1998) Q-fever endocarditis, clinical presentation and serological follow-up of 21 patients. SMW 128:740–744

Jacobs F, Abramowicz D, Vereerstraeten P, Le Clerc JL, Zech F, Thys JP (1990) Brucella endocarditis: the role of combined medical and surgical treatment. Rev Infect Dis 12:740–744

Raoult D, Fournier PE, Drancourt M, Marrie TJ, Etienne J, Cosserat J, Cacoub P, Poinsignon Y, Leclercq P, Sefton AM (1996) Diagnosis of 22 new cases of Bartonella endocarditis. Ann Intern Med 125:646–652

Siegman-Igra Y, Kaufman O, Keysary A, Rzotkiewicz S, Shalit I (1997) Q-fever endocarditis in Israel and a world wide review. Scand J Infect Dis 29:41–49

Drancourt M, Mainardi JL, Brouqui P, Vandenesch F, Carta A, Lehnert F, Etienne J, Goldstein F, Acar J, Raoult D (1995) Bartonella (Rochalimaea) quintana endocarditis in three homeless men. N Engl J Med 332:419–423

Raoult D (1999) Afebrile blood culture-negative endocarditis. Ann Intern Med 131:144–146

Saravolatz LD, Burch KH, Quinn EL, Cox F, Madhavan T, Fisher E (1978) Polymicrobial infective endocarditis: an increasing clinical entity. Am Heart J 95:163–168

Chambers HF, Miller RT, Newman MD (1988) Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann Intern Med 109:619–624

Heldman AW, Hartert TV, Ray SC, Daoud EG, Kowalski TE, Pompili VJ, Sisson SD, Tidmore WC, vom Eigen KA, Goodman SN, Lietman PS, Petty BG, Flexner C (1996) Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. Am J Med 101:68–76

Niebel J (1991) Infective Endocarditis in immune-compromised patients. In: Horstkotte D, Bodnar E (eds) Current Issues in Heart Valve Disease: Infective Endocarditis. ICR Publishers, London, p 154–163

Nahass RG, Weinstein MP, Bartels J, Gocke DJ (1990) Infective endocarditis in intravenous drug users: a comparison of human immunodeficiency virus type 1-negative and -positive patients. J Infect Dis 162:967–970

Pulvirenti JJ, Kerns E, Benson C, Lisowski J, Demarais P, Weinstein RA (1996) Infective endocarditis in injection drug users: importance of human immunodeficiency virus serostatus and degree of immunosuppression. Clin Infect Dis 22:40–45

Stamboulian D, Bonvehi P, Arevalo C, Bologna R, Cassetti I, Scilingo V, Efron E (1991) Antibiotic management of outpatients with endocarditis due to penicillin-susceptible streptococci. Rev Infect Dis 13(Suppl 2):S160–S163

Netzer RO, Altwegg SC, Zollinger E, Tauber M, Carrel T, Seiler C (2002) Infective endocarditis: determinants of long term outcome. Heart 88:61–66

Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM (2004) Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858–873

DiDomenico RJ, Park HY, Southworth MR, Eyrich HM, Lewis RK, Finley JM, Schumock GT (2004) Guidelines for acute decompensated heart failure treatment. Ann Pharmacother. 38:649–660

Graupner C, Vilacosta I, SanRoman J, Ronderos R, Sarria C, Fernandez C, Mujica R, Sanz O, Sanmartin JV, Pinto AG (2002) Periannular extension of infective endocarditis. J Am Coll Cardiol 39:1204–121

Rohmann S, Seifert T, Erbel R, Jakob H, Mohr-Kahaly S, Makowski T, Gorge G, Oelert H, Meyer J (1991) Identification of abscess formation in native-valve infective endocarditis using transesophageal echocardiography: implications for surgical treatment. Thorac Cardiovasc Surg 18:353–359

Chan KL (2002) Early clinical course and long-term outcome of patients with infective endocarditis complicated by perivalvular abscess. CMAJ 167:19–24

Rohmann S, Erbel R, Darius H, Makowski T, Meyer J (1997) Effect of antibiotic treatment on vegetation size and complication rate in infective endocarditis. Clin Cardiol 20:132–140

Vilacosta I, Graupner C, San Roman JA, Sarria C, Ronderos R, Fernandez C, Mancini L, Sanz O, Sanmartin JV, Stoermann W (2002) Risk of embolization after institution of antibiotic therapy for infective endocarditis.: J Am Coll Cardiol. 39:1489–1495

Horstkotte D, Schulte HD, Niehues R, Klein RM, Piper C, Strauer BE (1993) Diagnostic and therapeutic considerations in acute, severe mitral regurgitation: experience in 42 consecutive patients entering the intensive care unit with pulmonary edema. J Heart Valve Dis 2:212–222

Chastre J, Trouillet JL (1995) Early infective endocarditis on prosthetic valves. Eur Heart J 16(Suppl B):32–38

Piper C, Körfer R, Horstkotte D (2001) Prosthetic valve endocarditis. Heart 85:590–593

Hagl C, Galla JD, Lansman SL, Fink D, Bodian CA, Spielvogel D, Griepp RB (2002) Replacing the ascending aorta and aortic valve for acute prosthetic valve endocarditis: is using prosthetic material contraindicated? Ann Thorac Surg 74:S1781–S1785

Lytle BW, Sabik JF, Blackstone EH, Svensson LG, Pettersson GB, Cosgrove DM III (2002) Reoperative cryopreserved root and ascending aorta replacement for acute aortic prosthetic valve endocarditis. Ann Thorac Surg 74:S1754–S1757